Strategy Asset Managers’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Buy |
2,942
+99
| +3% | +$44.1K | 0.24% | 73 |
|
|
2025
Q1 | $1.38M | Buy |
2,843
+229
| +9% | +$111K | 0.28% | 69 |
|
|
2024
Q4 | $1.05M | Sell |
2,614
-95
| -4% | -$38.3K | 0.2% | 86 |
|
|
2024
Q3 | $1.26M | Sell |
2,709
-1,805
| -40% | -$839K | 0.24% | 74 |
|
|
2024
Q2 | $1.59M | Buy |
4,514
+2,116
| +88% | +$745K | 0.35% | 58 |
|
|
2024
Q1 | $1M | Sell |
2,398
-1,490
| -38% | -$623K | 0.21% | 77 |
|
|
2023
Q4 | $1.58M | Sell |
3,888
-188
| -5% | -$76.5K | 0.38% | 54 |
|
|
2023
Q3 | $1.42M | Sell |
4,076
-438
| -10% | -$152K | 0.37% | 55 |
|
|
2023
Q2 | $1.59M | Buy |
4,514
+264
| +6% | +$92.9K | 0.35% | 58 |
|
|
2023
Q1 | $1.34M | Buy |
4,250
+2,488
| +141% | +$784K | 0.33% | 62 |
|
|
2022
Q4 | $509K | Hold |
1,762
| – | – | 0.13% | 131 |
|
|
2022
Q3 | $510K | Buy |
1,762
+435
| +33% | +$126K | 0.14% | 135 |
|
|
2022
Q2 | $374K | Buy |
1,327
+139
| +12% | +$39.2K | 0.12% | 124 |
|
|
2022
Q1 | $310K | Buy |
+1,188
| New | +$310K | 0.07% | 198 |
|